Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes

M. Diamant, M.A. Nauck, R. Shaginian, J.K. Malone, S. Cleall, M. Reaney, D. de Vries, B.J. Hoogwerf, L. MacConell, B.H.R. Wolffenbuttel

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)2763-2773
JournalDiabetes Care
Volume37
Issue number10
DOIs
Publication statusPublished - 2014

Cite this

Diamant, M., Nauck, M. A., Shaginian, R., Malone, J. K., Cleall, S., Reaney, M., ... Wolffenbuttel, B. H. R. (2014). Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes. Diabetes Care, 37(10), 2763-2773. https://doi.org/10.2337/dc14-0876
Diamant, M. ; Nauck, M.A. ; Shaginian, R. ; Malone, J.K. ; Cleall, S. ; Reaney, M. ; de Vries, D. ; Hoogwerf, B.J. ; MacConell, L. ; Wolffenbuttel, B.H.R. / Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes. In: Diabetes Care. 2014 ; Vol. 37, No. 10. pp. 2763-2773.
@article{458cbdaa3ff942aab3c13ed57e3f6dd0,
title = "Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes",
author = "M. Diamant and M.A. Nauck and R. Shaginian and J.K. Malone and S. Cleall and M. Reaney and {de Vries}, D. and B.J. Hoogwerf and L. MacConell and B.H.R. Wolffenbuttel",
year = "2014",
doi = "10.2337/dc14-0876",
language = "Undefined/Unknown",
volume = "37",
pages = "2763--2773",
journal = "Diabetes Care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",
number = "10",

}

Diamant, M, Nauck, MA, Shaginian, R, Malone, JK, Cleall, S, Reaney, M, de Vries, D, Hoogwerf, BJ, MacConell, L & Wolffenbuttel, BHR 2014, 'Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes' Diabetes Care, vol. 37, no. 10, pp. 2763-2773. https://doi.org/10.2337/dc14-0876

Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes. / Diamant, M.; Nauck, M.A.; Shaginian, R.; Malone, J.K.; Cleall, S.; Reaney, M.; de Vries, D.; Hoogwerf, B.J.; MacConell, L.; Wolffenbuttel, B.H.R.

In: Diabetes Care, Vol. 37, No. 10, 2014, p. 2763-2773.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes

AU - Diamant, M.

AU - Nauck, M.A.

AU - Shaginian, R.

AU - Malone, J.K.

AU - Cleall, S.

AU - Reaney, M.

AU - de Vries, D.

AU - Hoogwerf, B.J.

AU - MacConell, L.

AU - Wolffenbuttel, B.H.R.

PY - 2014

Y1 - 2014

U2 - 10.2337/dc14-0876

DO - 10.2337/dc14-0876

M3 - Article

VL - 37

SP - 2763

EP - 2773

JO - Diabetes Care

JF - Diabetes Care

SN - 0149-5992

IS - 10

ER -